Atri, A., & Frölich, L. (2018). Effect of idalopirdine as adjunct to cholinesterase inhibitors on change in cognition in patients with alzheimer disease: Three randomized clinical trials. The journal of the American Medical Association, 319(2), . https://doi.org/10.1001/jama.2017.20373
Chicago Style (17th ed.) CitationAtri, Alireza, and Lutz Frölich. "Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients with Alzheimer Disease: Three Randomized Clinical Trials." The Journal of the American Medical Association 319, no. 2 (2018). https://doi.org/10.1001/jama.2017.20373.
MLA (9th ed.) CitationAtri, Alireza, and Lutz Frölich. "Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients with Alzheimer Disease: Three Randomized Clinical Trials." The Journal of the American Medical Association, vol. 319, no. 2, 2018, https://doi.org/10.1001/jama.2017.20373.